Trial site
University of Michigan Hospitals
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer3 trials
- Acute myeloid leukaemia2 trials
- Diffuse large B-cell lymphoma2 trials
- Epilepsy2 trials
- Lung cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Endometrial cancer1 trial
- and 7 more
- Phase
- Phase 34 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed2 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Boston Scientific Corporation4 trials
- Xenon Pharmaceuticals Inc.2 trials
- Endocyte1 trial
- Kura Oncology, Inc.1 trial
- Novartis Pharmaceuticals1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
Active, not recruiting
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Active, not recruiting
SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy2 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Completed
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Completed
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026